Muhammed is a PhD student in the Biomarker Discovery and Heart Failure Research labs. Under the guidance of Professor David Kaye and Associate Professor Bing Wang, Muhammed’s PhD focusses on clinically relevant animal models of heart failure with preserved ejection fraction (HFpEF). Namely, utilising these pre-clinical models to better understand the pathophysiology of the syndrome, elucidate novel biomarkers and therapeutics interventions to treat the condition.

Previously, Muhammed graduated from the Bachelor of Biomedical Science at Monash University in 2017. Subsequently, completing an honours project in Heart Failure Research group at the Baker Institute in 2023. Here he investigated the mechanisms underpinning the beneficial effects of SGLT2 inhibitors in a clinically relevant HFpEF model in mice.